Contextual Genomics, Personalized Medicine Initiative Launch Tumor Profiling Project in Canada | GenomeWeb

NEW YORK (GenomeWeb) – The Personalized Medicine Initiative and molecular diagnostics firm Contextual Genomics have teamed to launch a project in Canada that will use genetic tumor profiling to choose patient's medications, the partners said today.

PMI, a group of Canadian stakeholders focused on molecular medicine and based at the Life Sciences Institute at the University of British Columbia, will manage the initiative, called the National Access Project for Cancer Testing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.